RSS

report

Growth of $23 billion by the year 2021 is anticipated in the global cholesterol-lowering drugs market, according to a new report from business intelligence provider, Visiongain. more

Analysis

Nearly all supply chain and operations professionals are not fully capitalising on digitalisation technologies, according to new research from logistics company, DHL. more

Analysis

A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence has revealed that the UK has the strongest research and development (R&D) pipeline in Europe. more

Analysis

A new joint report from the Medicines Discovery Catapult and the UK BioIndustry Association (BIA), released today (Thursday 18 January) has revealed insights into the productivity of the UK’s drug discovery community. more

Analysis

The UK BioIndustry Association (BIA) has welcomed the release of the first progress report from the AMR Industry Alliance, which has assessed the action that is being taken to tackle antimicrobial resistance (AMR). more

News

A recent report from CPhI Japan has forecast that this year, 2018, will be a transformative year for Japanese pharma as the market is expected to see growth in generics, biosimilars and internationalisation. more

Analysis

To coincide with the House of Commons Health Select Committee hearing evidence on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the ABPI and the BIA release research on impact of UK’s exit from Europe more

News

CPhI Worldwide has revealed the finding from part i of its fifth edition of the CPhI Annual Report, which show the trend towards the integration of pharmaceutical outsourcing continues but the rate of change remains unclear. more

Analysis

Edison Investment Research, has released an independent and detailed analyst report into T-cell cancer therapies, highlighting the potential and limitations of current CAR-T approaches for most tumour types. more

Analysis

The latest report from business information and analytics provider, GlobalData, has indicated that immune-oncology (IO) will become the fifth pillar of cancer treatment, joining surgery, radiotherapy, chemotherapy and other targeted treatments. more

Analysis

In a report published today, the Medicines Manufacturing Industry Partnership (MMIP) has requested support from the government to build four new centres of excellence for medicines manufacturing across the UK. more

News

A new report from the manufacturers’ organisation, EEF, includes a call for the government to roll out devolution across England and to make it a key local growth priority within the Industrial Strategy. more

News

Global pharmaceutical and biopharmaceutical open access capability platform, WuXi AppTec, has published a report on immunotherapy, identifying that smaller biotech firms and early-stage companies will be the biggest driver behind therapy innovation. more

Analysis

CPhI Worldwide, organised by UBM, have announced the panel for the 2017 Annual Industry Report, which will represent the fifth edition. As such, a decision has been made to review the past five years’ reports to see how accurate the predictions were. more

Analysis

A recently published report, sponsored by Novartis, has described the potential benefits of the NHS only paying for drugs that actually work as a new model to address affordability and reduce risks within the health system. more

Analysis

The research and consulting firm, GlobalData, has released a report demonstrating the expected increase in the drug delivery devices market in the Asia-Pacific (APAC) region will be larger than that of North America over the same period to 2026. more

News

The manufacturers’ organisation, EEF, has warned of a potential recruitment crunch if Britain’s businesses are denied access to skills from across the European Union, which is highlighted in its report published today. more

News

A study from the Reputation Institute has shown that the reputation of the pharmaceutical industry is strong, with public perceptions improving across eight key markets, but competition within the industry is tight. more

News

A new report from UK limited liability partnership, KPMG, states that despite investment from the majority of manufacturers into industry 4.0 few have achieved the scale and integration required to drive enterprise value. more

News

The UK BioIndustry Association (BIA) has released a report confirming that the UK is on track to build the world’s third global biotech cluster. more

News